# Dt& Investment

> Dt& Investment is a VC fund in Seoul backing Biotechnology and E-Commerce. See 62 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Seoul, South Korea
- Total investments: 62
- Last investment: Jul 2026
- Lead investor: 5%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/dt-investment-디티앤인베스트먼트
- Website: https://dtni.co.kr/

Dt& Investment is a VC fund in Seoul focused on Biotechnology and E-Commerce. Dt& Investment brings the spirit of Ubuntu to the world of Venture Capital.

## Contacts

5 contacts available for Dt& Investment. Shizune tracks 1 team members at Dt& Investment. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/dt-investment?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $2k–$4.5M |
| Series A | $1.5M–$11M |
| Series B | $2.7M–$18M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 12 | 19% |
| E-Commerce | 9 | 15% |
| Health Care | 7 | 11% |
| Medical | 6 | 10% |
| Software | 6 | 10% |

92 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 21 | 34% |
| Series A | 18 | 29% |
| Seed | 12 | 19% |
| Series C | 6 | 10% |
| Venture - Series Unknown | 2 | 3% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 49 | 79% |
| Vietnam | 3 | 5% |
| United States | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Jo Dong gun | Executive Director | 1 | https://shizune.co/investors/profile/jo-dong-gun |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Inocras | Inocras Inc. specializes in whole genome sequencing and analytics, focusing on providing insights for personalized care in cancer and rare diseases. Utilizing artificial intelligence, Inocras aims to revolutionize healthcare by enabling precision medicine. The company offers services to patients, healthcare providers, researchers, and partners,seeking to unlock new possibilities in precision health. With a commitment to innovation, Inocras has introduced products like CancerVision and RareVision, designed to enhance diagnosis and treatment strategies through comprehensive genomic analysis. | $20K | Series B | Jul 01, 2026 |  |
| HANCOM InSpace | Inspace is an aerospace and geospatial intelligence company specializing in satellite ground systems and AI-based Earth observation services. It develops platforms for processing and analyzing satellite, drone, SAR, optical, and infrared imagery to support defense, environment, and commercial monitoring applications. The company also provides droneoperation systems and space data solutions, turning complex geospatial data into actionable intelligence for government and enterprise users. | $9M | Venture - Series Unknown | Aug 11, 2025 |  |
| Ettifos | They are a talented group of entrepreneurs and engineers with state-of-the art technologies that they hope will contribute towards a better future in the connected-car ecosystem. They provide smart solutions for companies of all sizes and pride theirselves on their unparalleled, dedicated connected-car solutions.At Ettifos Co., they believe thatthe right understanding of the customer's need can lead companies towards a successful future. They always seek valuable feedback from their partners in order to learn and evolve. Contact us today to set up a meeting with one of their representatives or request a demo. | $11M | Series B | Jul 02, 2025 |  |
| ROBOS | Robos is a hybrid robot system built by evaluating biological object vision data using Lidar Vision and Open CV-based Object Detection. By combining self-developed biomaterial machine vision technology and robot technology, it intends to expand into a company that delivers core services to diverse industrial sites such as manufacturing, food, andmedical. | $18.2M | Series B | Jun 18, 2025 |  |
| Works Mate | Works Mate is a job search matching platform for daily workers in the field of construction and architecture sectors. | $2.7M | Series B | Mar 27, 2025 |  |
| LISCure Biosciences | LISCure Biosciences is a developer of bacteria-mediated immunotherapy designed to treat tumors as well as degenerative neurological, autoimmune and metabolic diseases. The company currently has seven pipelines of medicine and two pipelines of health-functioning food and is considering the introduction of two more pipes. | $13.6M | Venture - Series Unknown | Jan 10, 2025 |  |
| Rowan | Rowan developed a solution which monitors the movement and location of the patients, staff and medical devices in real-time. The collected data is then analysed to predict the needs and provide the optimised distribution solution for each equipment. | $4.5M | Series B | Aug 21, 2024 |  |
| AiV | AiV is a technology company focused on developing advanced AI and deep learning solutions for industrial applications. It specializes in computer vision systems used for automation, inspection, and smart manufacturing processes. The company aims to improve industrial efficiency by combining AI software, data analytics, and machine learningtechnologies. | $15.3M | Series C | Aug 05, 2024 |  |
| BIGPICTURE | BIGPICTURE is an eSports and gaming company that develops platforms, tournaments, media content, and education services for gamers. The company operates across esports event management, gaming media, platform business, and marketing initiatives. | $10.1M | Series C | Mar 08, 2024 |  |
| ROBOS | Robos is a hybrid robot system built by evaluating biological object vision data using Lidar Vision and Open CV-based Object Detection. By combining self-developed biomaterial machine vision technology and robot technology, it intends to expand into a company that delivers core services to diverse industrial sites such as manufacturing, food, andmedical. | $5.2M | Series A | Feb 13, 2024 |  |

10 of 62 investments shown.

## Co-investors
- [Industrial Bank of Korea](https://shizune.co/investors/profile/industrial-bank-of-korea) — VC Fund, 10 deals together
- [Nau IB Capital](https://shizune.co/investors/profile/nau-ib-capital) — VC Fund, 10 deals together
- [IMM Investment](https://shizune.co/investors/profile/imm-investment) — VC Fund, 7 deals together
- [Colopl Next](https://shizune.co/investors/profile/colopl-next) — VC Fund, 5 deals together
- [K2 Investment Partners](https://shizune.co/investors/profile/k2-investment-partners) — VC Fund, 5 deals together
- [NH Capital](https://shizune.co/investors/profile/nh-capital) — VC Fund, 5 deals together

## Similar investors

### Similar industry
- [Reach Capital](https://shizune.co/investors/profile/reach-capital) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [GSV Ventures](https://shizune.co/investors/profile/gsv-acceleration) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Health Care Investors in South Korea](https://shizune.co/investors/health-care-investors-south-korea)
- [Health Care VC Funds in South Korea](https://shizune.co/investors/health-care-vc-funds-south-korea)
- [SaaS Investors in South Korea](https://shizune.co/investors/saas-investors-south-korea)
- [Biotech Investors in South Korea](https://shizune.co/investors/biotech-investors-south-korea)
- [Biotech VC Funds in South Korea](https://shizune.co/investors/biotech-vc-funds-south-korea)
- [Biotechnology Investors in South Korea](https://shizune.co/investors/biotechnology-investors-south-korea)

## FAQ

### What does Dt& Investment invest in?

Dt& Investment invests primarily in Biotechnology, E-Commerce and Health Care startups, most often at Series B and Series A stage. Most of the 62 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Dt& Investment's check size?

Dt& Investment typically joins rounds of $2k–$4.5M at Seed, $1.5M–$11M at Series A and $2.7M–$18M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Dt& Investment participates in.

### How do I contact Dt& Investment?

Public channels for Dt& Investment include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Dt& Investment?

The team at Dt& Investment includes Jo Dong gun (Executive Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co